Saturday, August 1, 2026

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

North Korea’s Kim Sends Birthday Message to Xi, Underscoring Deepening Ties With China

Kim Jong Un congratulates Xi Jinping on his birthday, reinforcing North Korea-China ties amid recent cooperation pledges.

Studies Show Fish Leads to Higher Testosterone Levels in Men

A recent study found that men over...

Tag: Yuhan

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us